Document Detail


Serum uric acid concentrations and arthralgia among patients treated with pyrazinamide-containing regimens in Hong Kong and Singapore.
MedLine Citation:
PMID:  7314249     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The serum uric acid concentrations of patients being treated in Hong Kong and Singapore with a daily regimen consisting of streptomycin, isoniazid, rifampicin and pyrazinamide or a control regimen of daily streptomycin, p-amino-salicylic acid (PAS) and isoniazid were determined by the phosphotungstate method. Arthralgia and elevated serum uric acid levels were encountered only during the period that patients were being treated with pyrazinamide. Although daily treatment with pyrazinamide increased serum uric acid concentrations approximately 2.5-fold, the concentrations of the 6 patients who developed arthralgia were closely similar to those of matched controls without arthralgia. This fails to confirm a previous suggestion that patients with arthralgia might have higher values. Rifampicin appeared not to influence the hyperuricaemic effect of pyrazinamide.
Authors:
P J Jenner; G A Ellard; W G Allan; D Singh; D J Girling; A J Nunn
Related Documents :
19861489 - Replication of the five novel loci for uric acid concentrations and potential mediating...
16568759 - Cyanogen chloride precursor analysis in chlorinated river water.
465979 - Familial renal hypouricaemia: two additional cases with uric acid lithiasis.
11475439 - Uric acid levels in patients with multiple sclerosis: analysis in mono- and dizygotic t...
2291249 - Prophylaxis of uric acid and cystine stones.
16100229 - Expression of allene oxide cyclase and accumulation of jasmonates during organogenic no...
6430889 - Spirulina ferredoxin-nadp+ reductase. the complete amino acid sequence.
6630869 - A simplified method for the estimation of individual amino acid radioactivity in plasma...
12575899 - Lipoxygenase and cyclooxygenase metabolism: new insights in treatment and chemopreventi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Tubercle     Volume:  62     ISSN:  0041-3879     ISO Abbreviation:  Tubercle     Publication Date:  1981 Sep 
Date Detail:
Created Date:  1982-02-12     Completed Date:  1982-02-12     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  1273730     Medline TA:  Tubercle     Country:  SCOTLAND    
Other Details:
Languages:  eng     Pagination:  175-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Humans
Joint Diseases / blood,  chemically induced*
Pyrazinamide / adverse effects*,  therapeutic use
Tuberculosis, Pulmonary / blood,  drug therapy*
Uric Acid / blood*
Chemical
Reg. No./Substance:
69-93-2/Uric Acid; 98-96-4/Pyrazinamide

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hereditary changes in gene activity as 1 of the causes of phenotypic heterogeneity in 8-azaguanine-r...
Next Document:  The pattern of age-specific tuberculin hypersensitivity in two groups of South African schoolchildre...